Is getting a kidney stone simply bad luck?

Once a kidney stone is large enough to require treatment, it’s been forming for as long as two years. Award-winning urologist Marshall Stoller, MD, who heads UC San Francisco’s urinary stone division, says there are many proven things you can control to keep your kidneys healthy, including increasing your intake of citrate.

“Kidney stones are happening to people at earlier ages these days. And the earlier you have a stone, the more likely you are to have chronic kidney disease later in life. Simple lifestyle changes, such as increasing your citrate levels by drinking Moonstone, may help your kidneys to stay healthier for the long term,” says Stoller.

He elaborates, “Citrate helps prevent stone formation by reducing the ability of calcium in the urine to bind with oxalate. Back in the early 90s, scientists found that lemonade increased citrate levels in the urine, but we now know that increase is not nearly high enough. To support daily kidney health with citrate, a better approach is to drink a citrate blend, developed by kidney health experts. Available over the counter as Moonstone Kidney Health Beverage, it contains the right amounts of citrate salts, lemon juice and vitamin B6 to optimize the body’s chemistry. It is also a convenient way to increase hydration.”

Stoller encourages everyone, even those without a personal or family history of kidney stones, to adopt a kidney-healthy lifestyle. His advice for keeping kidneys healthy includes:  

  • Limit your salt intake. “The recommended daily limit is 2,300 mg/day. Most people eat twice that much or more! The National Kidney Foundation has some great advice for preparing flavorful, low-sodium meals.”
  • Get plenty of calcium. “There’s a misconception among the healthcare and lay communities that calcium stone formers should avoid calcium. The opposite is true. If you have excess calcium in your urine, it could be coming from your bones. Replenishing your calcium supply supports overall health, especially your bones. High calcium diets are not associated with increased kidney stone risk.” 
  • Drink adequate amounts of fluid. “Moonstone is available in a convenient powdered drink mix. It comes in a variety of delicious flavors including Cranberry Raspberry and Lemon Lime. At less than the cost of your favorite macchiato, you’ll be doing something positive for your health,” says Stoller.

Marshall Stoller, MD is affiliated with Moonstone Nutrition.

Doctor uses his personal experience with kidney stones to help others

There’s a good chance you or someone you love will struggle with kidney stones. The condition affects about 1 out of 11 people during their lifetime. While some people pass stones with little to no difficulty, others suffer with immense pain, bleeding or further complications. David Goldfarb, M.D. suffered through a particularly tough case and it inspired him to help others struggling with the condition. 

The NYU-Langone School of Medicine professor will conduct a Facebook Live session about kidney stones and how to treat them on Wednesday, March 11th from 5 to 6 p.m. EDT. Those in the virtual audience will be able to ask Goldfarb questions about the condition and its management. Session participants also can win a prize package from Moonstone Kidney Health Beverage. To be eligible to win, participants must be residents of the United States, be age 18 or older and participate in the event’s comment feed. Three prize packages will be awarded. 

Facebook Live Kidney Health Q and A
March 11th from 5 to 6pm EDT
Dr. David Goldfarb

Moonstone is the first beverage scientifically designed to support kidney health. The patented drink is made with 30mEq of alkali-bound citrate, the only citrate proven to reduce kidney stones formation in most people. Moonstone is available as a great-tasting ready-to-drink beverage and as a convenient drink mix. 

Goldfarb is an acclaimed expert on kidney health. In addition to teaching kidney physiology at NYU School of Medicine and seeing patients who have a variety of kidney stones, Goldfarb has held several leadership positions in nephrology, the branch of medicine that focuses on kidney care. 

He serves on the medical advisory board of the National Kidney Foundation serving Greater New York, the scientific advisory board of the Oxalosis and Hyperoxaluria Foundation, and the board of directors of the International Cystinuria Foundation.

He is the principal investigator of the Rare Kidney Stone Consortium’s Cystinuria Project, which is funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Advancing Translational Sciences.

Previously, Goldfarb served as the associate editor of the Clinical Journal of the American Society of Nephrology for five years, and was the president of the Research on Calculus Kinetics Society (the R.O.C.K. Society) and the New York Society of Nephrology. He also served as vice chair of the American Urological Association’s guideline panel on the medical management of kidney stones, representing the American Society of Nephrology.

He was named “Stone Crusher of the Year” by the Oxalosis and Hyperoxaluria Foundation in 2014 and “Nephrologist of the Year” by the American Kidney Fund in 2016.